Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Hsin Chang

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Hepatology International|March 7, 2021
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in TaiwanChen-Hua Liu, Po-Yueh Chen, Jyh-Jou Chen, et al.
Hepatology International|January 26, 2023
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in TaiwanChen-Hua Liu, Cheng-Yuan Peng, Chun-Jen Liu, et al.
Intestinal Research|August 5, 2024
Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023Jia-Feng Wu, Hsu-Heng Yen, Horng-Yuan Wang, et al.
Intestinal Research|August 5, 2024
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023Hsu-Heng Yen, Jia-Feng Wu, Horng-Yuan Wang, et al.
Inflammatory Bowel Diseases|January 10, 2023
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) StudyWei-Chen Lin, Wei-Chen Tai, Chung-Hsin Chang, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Hepatology International|March 7, 2021
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in TaiwanChen-Hua Liu, Po-Yueh Chen, Jyh-Jou Chen, et al.
Hepatology International|January 26, 2023
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in TaiwanChen-Hua Liu, Cheng-Yuan Peng, Chun-Jen Liu, et al.
Intestinal Research|August 5, 2024
Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023Jia-Feng Wu, Hsu-Heng Yen, Horng-Yuan Wang, et al.
Intestinal Research|August 5, 2024
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023Hsu-Heng Yen, Jia-Feng Wu, Horng-Yuan Wang, et al.
Inflammatory Bowel Diseases|January 10, 2023
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) StudyWei-Chen Lin, Wei-Chen Tai, Chung-Hsin Chang, et al.
Pageof 5